# Stereotaxis Completes Acquisition of Robocath to Accelerate Endovascular Robotics

> ma · REPORTED · 2026-07-13

Stereotaxis completed its acquisition of Robocath, a French medical robotics company, with the intention of accelerating development of next-generation robotic technologies for endovascular procedures. The deal expands Stereotaxis's robotic platform capabilities beyond cardiac electrophysiology into broader vascular intervention.

About Stereotaxis: Stereotaxis is a medical robotics company that develops and commercializes robotic navigation systems for minimally invasive cardiac electrophysiology procedures, enabling physicians to guide catheters remotely with precision.

- Company: Stereotaxis
- Sector: medical devices
- Primary source: https://www.medtechdive.com/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.